查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1381031

粒子治療市場：按治療類型、成分、癌症類型和最終用戶 - 2023-2030 年全球預測

Particle Therapy Market by Therapy Type (Fast-Neutron Therapy, Heavy Ion Therapy, Proton Therapy), Component (Products, Systems), Cancer Type, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

粒子治療市場預計將從 2022 年的 6.7852 億美元增至 2030 年的 12.4267 億美元，預測期內年複合成長率為 7.85%。

粒子束治療的全球市場

主要市場統計
市場金額：基準年 [2022] 67852萬美元
預計市場金額[2023] 7.2344億美元
預計市場金額[2030]12.4267億美元 12.4267億美元
年複合成長率（%） 7.85%
粒子束治療市場-IMG1

FPNV定位矩陣

FPNV定位矩陣是評估粒子治療市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.粒子束治療市場的市場規模與預測是多少？

2. 粒子治療市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.粒子束治療市場的競爭策略窗口是什麼？

4.粒子束治療市場的最新技術趨勢和法律規範是什麼？

5.粒子束治療市場主要廠商的市場佔有率是多少？

6.進入粒子束治療市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 癌症治療需要先進的治療方法
      • 在臨床試驗中更多地採用粒子療法
      • 更多採用快速、非侵入性和無痛手術
    • 抑制因素
      • 粒子治療的保險範圍有限
    • 機會
      • 正在進行的質子治療調查計畫
      • 帶電粒子治療的技術進步
    • 任務
      • 新興國家患者缺乏對粒子束治療的認知
      • 與粒子束治療輻射暴露相關的風險
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 依治療類型分類的粒子束治療市場

  • 快中子治療
  • 重粒子線治療
  • 質子治療

第7章 粒子治療市場：依組成部分

  • 產品
    • 迴旋加速器
    • 同步迴旋加速器
    • 同步加速器
  • 系統
    • 多房間系統
    • 包房系統

第8章 按癌症類型分類的粒子治療市場

  • 乳癌
  • 頭頸癌
  • 肺癌
  • 兒童癌症
  • 攝護腺癌

第9章 粒子治療市場：依最終使用者分類

  • 門診手術中心
  • 醫院和診所

第10章 美洲粒子治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太粒子治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲粒子治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Advanced Oncotherapy plc
    • Danfysik A/S
    • Elekta AB
    • Hitachi, Ltd.
    • IBA International
    • Koninklijke Philips NV
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • Optivus Proton Therapy, Inc.
    • ProTom International
    • Provision Healthcare, LLC
    • PTW Freiburg GmbH
    • SAH Global LLC
    • Sumitomo Heavy Industries, Ltd.
    • Toshiba Medical Systems Corporation
    • Varian Medical Systems, Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-335201F2E2D7

The Particle Therapy Market is projected to reach USD 1,242.67 million by 2030 from USD 678.52 million in 2022, at a CAGR of 7.85% during the forecast period.

Global Particle Therapy Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 678.52 million
Estimated Year Value [2023] USD 723.44 million
Forecast Year Value [2030] USD 1,242.67 million
CAGR (%) 7.85%
Particle Therapy Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Particle Therapy Market.

Based on Therapy Type, market is studied across Fast-Neutron Therapy, Heavy Ion Therapy, and Proton Therapy. The Proton Therapy is projected to witness significant market share during forecast period.

Based on Component, market is studied across Products and Systems. The Products is further studied across Cyclotrons, Synchrocyclotrons, and Synchrotrons. The Systems is further studied across Multi-Room Systems and Single-Room Systems. The Systems is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Breast Cancer, Head & Neck Cancer, Lung Cancer, Pediatric Cancer, and Prostate Cancer. The Prostate Cancer is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Particle Therapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Particle Therapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Optivus Proton Therapy, Inc., ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Varian Medical Systems, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Particle Therapy Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Particle Therapy Market?

3. What is the competitive strategic window for identifying opportunities in the Particle Therapy Market?

4. What are the latest technology trends and regulatory frameworks in the Particle Therapy Market?

5. What is the market share of the leading vendors in the Particle Therapy Market?

6. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Particle Therapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advanced therapies in cancer treatment
      • 5.1.1.2. Rise in adoption of particle therapy in clinical trials
      • 5.1.1.3. Increasing adoption of fast, non-invasive, and painless procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited insurance coverage for particle therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing proton therapy research programs
      • 5.1.3.2. Technological advances in charged-particle therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness in patients about particle therapy in the emerging economies
      • 5.1.4.2. Risk associated with the particle therapy radiation exposure
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Particle Therapy Market, by Therapy Type

  • 6.1. Introduction
  • 6.2. Fast-Neutron Therapy
  • 6.3. Heavy Ion Therapy
  • 6.4. Proton Therapy

7. Particle Therapy Market, by Component

  • 7.1. Introduction
  • 7.2. Products
    • 7.3.1. Cyclotrons
    • 7.3.2. Synchrocyclotrons
    • 7.3.3. Synchrotrons
  • 7.3. Systems
    • 7.4.1. Multi-Room Systems
    • 7.4.2. Single-Room Systems

8. Particle Therapy Market, by Cancer Type

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Head & Neck Cancer
  • 8.4. Lung Cancer
  • 8.5. Pediatric Cancer
  • 8.6. Prostate Cancer

9. Particle Therapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospitals & Clinics

10. Americas Particle Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Particle Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Particle Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Advanced Oncotherapy plc
    • 14.1.2. Danfysik A/S
    • 14.1.3. Elekta AB
    • 14.1.4. Hitachi, Ltd.
    • 14.1.5. IBA International
    • 14.1.6. Koninklijke Philips N.V.
    • 14.1.7. Mevion Medical Systems
    • 14.1.8. Mitsubishi Electric Corporation
    • 14.1.9. Optivus Proton Therapy, Inc.
    • 14.1.10. ProTom International
    • 14.1.11. Provision Healthcare, LLC
    • 14.1.12. PTW Freiburg GmbH
    • 14.1.13. SAH Global LLC
    • 14.1.14. Sumitomo Heavy Industries, Ltd.
    • 14.1.15. Toshiba Medical Systems Corporation
    • 14.1.16. Varian Medical Systems, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PARTICLE THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
  • FIGURE 7. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 10. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
  • FIGURE 12. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PARTICLE THERAPY MARKET SIZE, BY FAST-NEUTRON THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 10. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 17. PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 279. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 280. PARTICLE THERAPY MARKET LICENSE & PRICING